Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation.

Saved in:
Bibliographic Details
Title: Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation.
Authors: Mitchell JS; Thompson Institute, University of the Sunshine Coast, 12 Innovations Parkway, Birtinya, 4575, Sunshine Coast, QLD, Australia. jules.mitchell@research.usc.edu.au., Hermens DF; Thompson Institute, University of the Sunshine Coast, 12 Innovations Parkway, Birtinya, 4575, Sunshine Coast, QLD, Australia., Bennett MR; Brain & Mind Research Centre, University of Sydney, Sydney, NSW, Australia., Can AT; Thompson Institute, University of the Sunshine Coast, 12 Innovations Parkway, Birtinya, 4575, Sunshine Coast, QLD, Australia., Lagopoulos J; Thompson Institute, University of the Sunshine Coast, 12 Innovations Parkway, Birtinya, 4575, Sunshine Coast, QLD, Australia.
Source: CNS drugs [CNS Drugs] 2023 Feb; Vol. 37 (2), pp. 159-180. Date of Electronic Publication: 2023 Jan 22.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36681939
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mitchell+JS%22">Mitchell JS</searchLink>; Thompson Institute, University of the Sunshine Coast, 12 Innovations Parkway, Birtinya, 4575, Sunshine Coast, QLD, Australia. jules.mitchell@research.usc.edu.au.<br /><searchLink fieldCode="AU" term="%22Hermens+DF%22">Hermens DF</searchLink>; Thompson Institute, University of the Sunshine Coast, 12 Innovations Parkway, Birtinya, 4575, Sunshine Coast, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Bennett+MR%22">Bennett MR</searchLink>; Brain & Mind Research Centre, University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Can+AT%22">Can AT</searchLink>; Thompson Institute, University of the Sunshine Coast, 12 Innovations Parkway, Birtinya, 4575, Sunshine Coast, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Lagopoulos+J%22">Lagopoulos J</searchLink>; Thompson Institute, University of the Sunshine Coast, 12 Innovations Parkway, Birtinya, 4575, Sunshine Coast, QLD, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229431220%22">CNS drugs</searchLink> [CNS Drugs] 2023 Feb; Vol. 37 (2), pp. 159-180. <i>Date of Electronic Publication: </i>2023 Jan 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9431220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211727047%22">11727047 </searchLink><i>NLM ISO Abbreviation: </i>CNS Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36681939
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40263-022-00984-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 159
    Titles:
      – TitleFull: Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mitchell JS
      – PersonEntity:
          Name:
            NameFull: Hermens DF
      – PersonEntity:
          Name:
            NameFull: Bennett MR
      – PersonEntity:
          Name:
            NameFull: Can AT
      – PersonEntity:
          Name:
            NameFull: Lagopoulos J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2023 Feb
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1934
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: CNS drugs
              Type: main
ResultId 1